home contact company.overview news sitemap print

Screening & Optimization
Structure-based Drug Design
Stem Cell-based Approaches
Cardiac Safety

Full Range of Cellular Assays
Gene Editing
Chromobody and Custom Cell Lines
Tumor Biology


DigiWest High Content Profiling
RPPA-based Pathway Mapping
Ultrasensitive Protein Profiling
Custom Multiplex Immunoassays


GMP Analysis
Method Development and Validation
Consulting for GMP or GLP Issues

   

NMI TT is a subsidiary of NMI